December 3, 2004

Analysts estimate Merck's liability for the Vioxx Recall to reach $38 billion

Analyst Richard Evans at Stanford C. Bernstein wrote in a research report that Merck's liability for the withdrawn arthritis painkiller Vioxx could reach $38 billion. This number is based off the assumption that 58,000 heart attacks could be linked to the drug, with an average settlement being $650,000.

Evans wrote Merck's share price assumes about $25 billion in risk. He pointed out that while it is unclear how the Vioxx lawsuits will result, given that they win settlement or at jury Evans said liability is likely to far exceed his previous estimates.

For more information on the Vioxx recall, please contact us to confer with a Vioxx Recall Lawyer and learn your legal rights and options.

 

Click here for more Vioxx news....

 

 

 

 

 

Back to Top ^